½ÃÀ庸°í¼­
»óǰÄÚµå
1263168

¼¼°èÀÇ ÀÚ°¡ÁÖ»ç ½ÃÀå ¸®Æ÷Æ®(2023³â)

Self-Injections Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀÚ°¡ÁÖ»ç ¼¼°è ½ÃÀåÀº 2022³â 407¾ï ´Þ·¯¿¡¼­ 2023³â¿¡´Â 512¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGR 25.83%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ ¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î COVID-19 ÆÒµ¥¹ÍÀÇ ¼¼°è °æÁ¦ ȸº¹ÀÇ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ µÎ ³ª¶ó °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁ® »óǰ ¹× ¼­ºñ½º Àü¹Ý¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ ¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÚ°¡ÁÖ»ç ½ÃÀåÀº CAGR 23.01%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2027³â¿¡ 1,172¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â ÀÚ°¡ÁÖ»ç ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ °¡Àå Å« Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. ÀÌ º¸°í¼­ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, Áßµ¿ À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

´ç´¢º´ ȯÀÚ Áõ°¡´Â ¾ÕÀ¸·Î ÀÚ°¡ÁÖ»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´À̶õ, Àν¶¸°À» ºÐºñÇÏ´Â Àΰ£ÀÇ Àå±âÀÎ ÃéÀåÀÇ Àν¶¸° ºÐºñ·®ÀÌ ÃæºÐÇÏÁö ¾Ê°í, Ç÷´çÄ¡ÀÇ ºÐÇØ°¡ ÁøÇàµÇ¾î, ½ÉÀ庴, ½Ã·Â ÀúÇÏ, ½ÅÀ庴 µî ½É°¢ÇÑ °Ç°­ »óŸ¦ ÀÏÀ¸Å°´Â »óŸ¦ ¸»ÇÕ´Ï´Ù. ÀÚ°¡ÁÖ»ç´Â ´ç´¢º´ ȯÀÚ°¡ ÀÇ·á Á¾»çÀÚÀÇ µµ¿ò¾øÀÌ ¾ðÁ¦µçÁö ÃÖÀûÀÇ Ç÷´çÀ» À¯ÁöÇÏ°í °úµµÇÑ Ç÷´çÀ» Â÷´ÜÇÏ´Â µ¥ µµ¿òÀ̵Ǵ Àν¶¸° ¹× ±âŸ ¾à¹°À» ÁÖÀÔÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î º§±â¿¡¿¡ º»ºÎ¸¦ µÎ°í 160°³ ÀÌ»óÀÇ ±¹°¡¿Í Áö¿ª 230°³±¹ÀÇ ´ç´¢º´Çùȸ¸¦ ´ëÇ¥ÇÏ´Â Á¶Á÷ÀÎ ±¹Á¦´ç´¢º´¿¬ÇÕ(IDF)¿¡ µû¸£¸é 2021³â¿¡´Â 20¼¼¿¡¼­ 79¼¼ÀÇ ¼ºÀÎ 5¾ï 6,700 ¸¸¸íÀÌ ÇöÀç ´ç´¢º´°ú °øÁ¸Çϰí ÀÖÀ¸¸ç, ´ç´¢º´ ȯÀÚÀÇ ¼ö´Â Áõ°¡Çϰí 2030³â¿¡´Â 6¾ï 4,300¸¸¸í¿¡, 2045³â¿¡´Â 7¾ï 8,300¸¸¸í¿¡ À̸¦ °ÍÀ¸·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù. ±×·¯¹Ç·Î ´ç´¢º´ ȯÀÚ ¼ö Áõ°¡´Â ÀÚ°¡ÁÖ»ç ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀÚ°¡ÁÖ»ç ½ÃÀå Æ¯Â¡

Á¦3Àå ÀÚ°¡ÁÖ»ç ½ÃÀåÀÇ µ¿Çâ°ú Àü·«

Á¦4Àå ÀÚ°¡ÁÖ»ç ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19 ÀÚ°¡ÁÖ»ç ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¿Í ·¯½Ã¾ÆÀÇ ÀüÀïÀÌ ÀÚ°¡ÁÖ»ç ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ÀÚ°¡ÁÖ»ç ½ÃÀå¿¡ ´ëÇÑ °íÀÎÇ÷¹À̼ÇÀÇ ¿µÇâ

Á¦5Àå ÀÚ°¡ÁÖ»ç ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå ÀÚ°¡ÁÖ»ç ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µð¹ÙÀ̽º
  • Á¦Çü
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, °ü¸® °æ·Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇǺÎ
  • ¼øÈ¯±â ¶Ç´Â ±Ù°ñ°Ý
  • Àå±â
  • ÁßÃ߽Űæ°è
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, ¿ë·®º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Single Dose
  • Multi Dose
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀÚ°¡¸é¿ªÁúȯ
  • È£¸£¸ó Àå¾Ö
  • Á¾¾çÇÐ
  • Èñ±Í Áúȯ
  • ÅëÁõ °ü¸®
  • È£Èí¿ä¹ý
  • ±âŸ ¿ëµµ
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • º´¿ø ¾à±¹
  • Áø·á¼Ò
  • È­ÇÐÀÚ
  • ¿Â¶óÀÎ ¾à±¹

Á¦7Àå ÀÚ°¡ÁÖ»ç ½ÃÀåÀÇ Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°è ÀÚ°¡ÁÖ»ç ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ±ÔÁ¦, ±ÔÁ¦ ±â°ü, ÁÖ¿ä ´Üü, °ú¼¼µÇ´Â ¼¼±Ý, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • Áß±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • Áß±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå Àεµ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • Àεµ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ» ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ÀϺ» ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ» ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • È£ÁÖ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • Àεµ³×½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • Çѱ¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ¼­À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • ¼­À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ¿µ±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • µ¶ÀÏ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½ºÀÇ ÀÚ°¡ÁÖ»ç¾à ½ÃÀå

  • ÇÁ¶û½º ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½º ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • µ¿À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • µ¿À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ·¯½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾Æ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ºÏ¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • ºÏ¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ÀÇ ÀÚ°¡ÁÖ»ç¾à ½ÃÀå

  • ¹Ì±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • ¹Ì±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ³²¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • ³²¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹Ì ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁú ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ºê¶óÁú ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁú ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ ÀÚ°¡ÁÖ»ç ½ÃÀå

  • Áßµ¿ ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • Áßµ¿ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä« ÀÚ°¡ÁÖ»ç ½ÃÀå

  • ¾ÆÇÁ¸®Ä« ÀÚ°¡ÁÖ»ç ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä« ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä« ÀÚ°¡ÁÖ»ç ½ÃÀå, À¯Åëä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå ÀÚ°¡ÁÖ»ç ½ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÀÚ°¡ÁÖ»ç ½ÃÀå °æÀï ±¸µµ
  • ÀÚ°¡ÁÖ»ç ½ÃÀå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • AbbVie Inc.
    • Antares Pharma Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Credence MedSystems Inc.

Á¦28Àå ÀÚ°¡ÁÖ»ç ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦29Àå ÀÚ°¡ÁÖ»ç ½ÃÀå Àü¸Á°ú ÀáÀ缺 ºÐ¼®

Á¦30Àå ºÎ·Ï

LSH 23.05.02

“Self-Injections Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on self-injections market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for self-injections? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The self-injections market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Devices; Formulations
  • 2) By Route Of Administration: Skin; Circulatory or Musculoskeletal; Organs; Central Nervous System
  • 3) By Dosage: Single Dose; Multi Dose
  • 4) By Application: Autoimmune Diseases; Hormonal Disorders; Oncology; Orphan Diseases; Pain Management; Respiratory Therapy; Other Applications
  • 5) By Distribution Channel: Hospitals Pharmacies; Clinics; Chemist; Online Pharmacies
  • Companies Mentioned: AbbVie Inc.; Antares Pharma Inc.; Baxter International Inc.; Becton, Dickinson and Company; Credence MedSystems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the self-injections market are: AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Becton, Dickinson and Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Group, Bristol-Myers Squibb Company, Scintilla Pharmaceuticals Inc., Merck & Co. Inc., and Bayer AG.

The global self injections market is expected to grow from $40.70 billion in 2022 to $51.22 billion in 2023 at a compound annual growth rate (CAGR) of 25.83%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The self injections market is expected to reach $117.26 billion in 2027 at a CAGR of 23.01%.

The self injections market consists of sales of auto-injectors, needle-free injectors, pen injectors and wearable injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Self-injection refers to a device used for the act of injecting oneself. Self-injections enable patients and users to administer medicines and drugs that need to be injected into them by themselves without the need for a physician or a medical professional.

North America was the largest region in the self injections market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main type of self injections are devices and formulations. The devices are used to enables patients and users to give medications and pharmaceuticals that require injection into them without the help of a doctor or other medical professional. Self-injection devices refers to devices that can be used by patients to self-administer medication that needs to be injected. The various route of administration includes skin, circulatory or musculoskeletal, organs, central nervous system. The various types of dosage include single dose and multi dose. The various types of applications include autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, and other applications and distribution channel includes hospitals pharmacies, clinics, chemist, and online pharmacies.

The growing number of diabetic patients is expected to propel the growth of the self-injections market going forward. Diabetes refers to a condition where the pancreas, a human organ that produces insulin, produce less than an adequate level of insulin which leads to the breakdown of blood sugars and causes serious health conditions like heart disease, vision loss, and kidney diseases. Self-injections can be used by diabetic patients for injecting insulin and other medications which help maintain optimum blood sugar levels and block any excess blood sugars at any given point of time without the help of a medical professional. For instance, according to International Diabetes Federation (IDF), a Belgium-based organization that represents 230 national diabetes associations in more than 160 countries and territories, in 2021, 567 million adults aged between 20 to 79 years are currently living with diabetes, and the number of diabetic patients is expected to grow and reach 643 million by 2030 and 783 million by 2045. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.

Technological advancement is a key trend in the self-injections market. Major companies in the market are concentrating on technological innovations s to sustain their position in the market. For instance, in October 2020, Aptar Pharma, a US-based drug device manufacturing company launched AdhereIT, a connected, intuitive, and user-friendly auto-injectors. This is the first fully interchangeable, auto-injectors that work across a multitude of auto-injector platforms. AdhereIT pairs a patient's auto-injector with the existing software applications via Bluetooth technology to their mobile phone.

In June 2022, Dr Reddy Labs, an India-based manufacturer of pharmaceuticals acquired an injectable portfolio from Eton Pharma for $50 million. With this acquisition, Dr. Reddy's aimed to accelerate and expand affordable medications for patients. Also, it enters into new portfolios such as injection and recipes. Eton Pharma is a US-based manufacturer of pharmaceuticals and injections.

The countries covered in the Self-Injections market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The self injections market research report is one of a series of new reports from The Business Research Company that provides self injections market statistics, including self injections industry global market size, regional shares, competitors with a self injections market share, detailed self injections market segments, market trends and opportunities, and any further data you may need to thrive in the self injections industry. This self injections market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Self-Injections Market Characteristics

3. Self-Injections Market Trends And Strategies

4. Self-Injections Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Self-Injections Market
  • 4.2. Ukraine-Russia War Impact On Self-Injections Market
  • 4.3. Impact Of High Inflation On Self-Injections Market

5. Self-Injections Market Size And Growth

  • 5.1. Global Self-Injections Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Self-Injections Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Self-Injections Market Segmentation

  • 6.1. Global Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Devices
  • Formulations
  • 6.2. Global Self-Injections Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Skin
  • Circulatory Or Musculoskeletal
  • Organs
  • Central Nervous System
  • 6.3. Global Self-Injections Market, Segmentation By Dosage, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Single Dose
  • Multi Dose
  • 6.4. Global Self-Injections Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.5. Global Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Hospitals Pharmacies
  • Clinics
  • Chemist
  • Online Pharmacies

7. Self-Injections Market Regional And Country Analysis

  • 7.1. Global Self-Injections Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Self-Injections Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Self-Injections Market

  • 8.1. Asia-Pacific Self-Injections Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Self-Injections Market

  • 9.1. China Self-Injections Market Overview
  • 9.2. China Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Self-Injections Market

  • 10.1. India Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Self-Injections Market

  • 11.1. Japan Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Self-Injections Market

  • 12.1. Australia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Self-Injections Market

  • 13.1. Indonesia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Self-Injections Market

  • 14.1. South Korea Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Self-Injections Market

  • 15.1. Western Europe Self-Injections Market Overview
  • 15.2. Western Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Self-Injections Market

  • 16.1. UK Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Self-Injections Market

  • 17.1. Germany Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Self-Injections Market

  • 18.1. France Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Self-Injections Market

  • 19.1. Eastern Europe Self-Injections Market Overview
  • 19.2. Eastern Europe Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Self-Injections Market

  • 20.1. Russia Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Self-Injections Market

  • 21.1. North America Self-Injections Market Overview
  • 21.2. North America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Self-Injections Market

  • 22.1. USA Self-Injections Market Overview
  • 22.2. USA Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Self-Injections Market

  • 23.1. South America Self-Injections Market Overview
  • 23.2. South America Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Self-Injections Market

  • 24.1. Brazil Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Self-Injections Market

  • 25.1. Middle East Self-Injections Market Overview
  • 25.2. Middle East Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Self-Injections Market

  • 26.1. Africa Self-Injections Market Overview
  • 26.2. Africa Self-Injections Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Self-Injections Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Self-Injections Market Competitive Landscape And Company Profiles

  • 27.1. Self-Injections Market Competitive Landscape
  • 27.2. Self-Injections Market Company Profiles
    • 27.2.1. AbbVie Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Antares Pharma Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Baxter International Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Becton, Dickinson and Company
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Credence MedSystems Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Self-Injections Market

29. Self-Injections Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦